Elizabeth Sugarمشاهده پروفایل
استاد پژوهشی
Elizabeth Sugar, PhD, MS is a Research Professor in the Department of Biostatistics at Johns Hopkins University's Bloomberg School of Public Health, with a joint appointment in Epidemiology. Her work spans multiple domains including ophthalmology, respiratory medicine, and oncology, focusing on the statistical design and analysis of complex clinical trials and observational studies. Dr. Sugar earned her PhD from the University of Washington, Seattle in 2003, her MS from the University of California, Santa Barbara in 1997, and her BA from Pomona College in 1995. Her educational background has provided a strong foundation for her work in biostatistics and clinical research methodology. Her primary research interests center on biostatistics, clinical trials, and longitudinal cohort studies. She has made significant contributions to ophthalmology research, particularly through her leadership in the Multicenter Uveitis Steroid Treatment (MUST) Trial where she served as Chair of the Statistical Committee. Her work in respiratory medicine has focused on asthma and COPD clinical trials, while her oncology research has concentrated on pancreatic cancer trials and vaccine development. Dr. Sugar's expertise spans both early-stage (Phase I/II) and late-stage (Phase III) clinical trials across multiple therapeutic areas. Analysis of her recent publications reveals a strong focus on uveitis and macular edema treatment outcomes, pancreatic cancer immunotherapy trials, and respiratory health studies. Her research demonstrates methodological rigor in clinical trial design, with particular emphasis on statistical approaches for complex ophthalmological and respiratory conditions. She frequently collaborates with multidisciplinary teams across Johns Hopkins and national research consortia. Dr. Sugar has been instrumental in major clinical trials including the MUST Trial, the Zoster Eye Disease Study (ZEDS), and multiple pancreatic cancer vaccine trials. Her work has consistently focused on improving clinical trial methodology and statistical approaches for complex disease areas. She leads statistical components of multiple large-scale clinical trials, particularly in ophthalmology where she has established herself as a leading biostatistician for uveitis research. Her laboratory work focuses on developing and applying advanced statistical methods for clinical trial analysis, with particular expertise in longitudinal data analysis and complex trial designs.
